Home » Topics » Financings » Grant

Grant
RSS

Neurology/Psychiatric

Washington University researchers receive funding to better understand pain

Nov. 7, 2022

Scientists at Washington University School of...

Cancer

CV6 secures funding to support progression of DNA uracilation agent CV6-168 into clinic

Nov. 3, 2022

CV6 Therapeutics (NI) Ltd. has secured US$9.2 million to progress its lead oncology asset CV6-168 into a first-in-human phase Ia trial and perform further scientific development work. CV6-168 is a novel, first-in-class DNA uracilation agent that selectively targets the enzyme dUTPase.

Cardiovascular

New NIH grant supports Vivasc's work to reverse molecular causes of heart failure

Oct. 20, 2022

Vivasc Therapeutics Inc. has initiated work under a second National Institutes of Health (NIH) phase I STTR research grant, in conjunction with Georgetown University.

Cancer

University of Queensland researchers receive funding for research in mRNA and cancer vaccines

Oct. 17, 2022

Researchers at the University of Queensland have been awarded funding to advance work across mRNA research, cancer vaccines and single-cell genomic technologies.

Neurology/Psychiatric

Metriopharm receives grant to support preclinical studies with MP-1032 for DMD

Oct. 13, 2022

Metriopharm AG has received a grant of €125,000 from charity Duchenne UK that will support development of the company's lead compound MP-1032 (luminol sodium salt) for the treatment of Duchenne muscular dystrophy (DMD).

Immune

CEPI awards funding to Intravacc to advance betacoronavirus vaccine candidate

Oct. 7, 2022

CEPI, the Coalition for Epidemic Preparedness Innovations, will provide seed funding of up to $4.8 million to Intravacc BV to advance the development of a broadly protective betacoronavirus vaccine candidate, which can be delivered intranasally.

Dental

Virtici receives SBIR award to advance VTC-886 for periodontitis

Oct. 7, 2022

Virtici LLC has been granted a Small Business Innovation Research (SBIR) award by the National Institute of Dental and Craniofacial Research (NIDCR) of the National Institutes of Health (NIH) to advance VTC-886, a first-in-class small molecule for the prevention of Porphyromonas gingivalis infection.

Neurology/Psychiatric

NIA award supports Oligomerix's development of tau self-association small-molecule inhibitor

Oct. 6, 2022

Oligomerix Inc. has been awarded US$2.49 million from the National Institute on Aging (NIA) to support clinical development of its lead...

Coronal plane slices of the brain comparing normal to Alzheimer’s.

Neurology/Psychiatric

NIA award supports Praetego's development of PTG-630 for Alzheimer's disease

Oct. 5, 2022

Praetego Inc. has been awarded a US$2.5 million phase II Small Business Technology Transfer (STTR) award from the National Institute on Aging (NIA) to its advance lead candidate, PTG-630, for Alzheimer's disease.

Cardiovascular

NIH awards support Aqualung Therapeutics' development of ALT-100 for PAH and IBD

Sep. 22, 2022

Aqualung Therapeutics Corp. has been awarded two 3-year National Institutes of Health (NIH) Fast Track awards to support development of ALT-100 (enamptcumab), a humanized monoclonal antibody therapy for the chronic indications of pulmonary arterial hypertension (PAH) and inflammatory bowel disease (IBD).

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
Amlogenyx’s AM-805 reduces amyloid plaques in AD
BioWorld Science
The potent carboxypeptidase enzyme protective protein cathepsin A (PPCA) is known to cleave the C-terminus of amyloid-β42, responsible for aggregation and...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Atai Therapeutics patents new 5-HT2 receptor agonists
BioWorld Science
Atai Therapeutics Inc. has identified new 5-HT2 receptor agonists potentially useful for the treatment of psychiatric disorders.

Grant RSS

Grant
RSS